Immunophenotypic characterisation of acute leukaemia after polycythemia vera. [PDF]
, 1993 Jesús María Hernández‐Rivas +7 more
openalex +1 more source
Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3. [PDF]
, 1991 Chunhua Dai +4 more
openalex +1 more source
Current management strategies for polycythemia vera and essential thrombocythemia.
Blood reviews, 2020 P. Guglielmelli, A. Vannucchi
semanticscholar +1 more source
Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor [PDF]
, 1992 Chunhua Dai +5 more
openalex +1 more source
Chronic myelomonocytic leukemia as a transformation from polycythemia vera
Leukemia Research Reports, 2019 The hallmark of Polycythemia vera (PV) is the presence of JAK2V617F mutation and increased RBC mass. Chronic myelomonocytic leukemia (CMML) is defined as persistent blood absolute monocyte count (AMC) >/= 1 × 109/L for at least 3 months with myeloid cell
Mirela Andrei +3 more
doaj
Erythematous Macular Eruption in an Older Woman [PDF]
, 2019 Kernohan, Neil +2 more
core +2 more sources
Polycythemia vera and arterial oxygen saturation
, 1963 Richard A. Bader +2 more
openalex +1 more source
Recombinant interferon alpha in the treatment of polycythemia vera [letter; comment] [PDF]
, 1991 E Cacciola +5 more
openalex +1 more source
Treatment of Polycythemia Vera: Use of 32P Alone or in Combination With Maintenance Therapy Using Hydroxyurea in 461 Patients Greater Than 65 Years of Age [PDF]
, 1997 Y Najean, Jean‐Didier Rain
openalex +1 more source